| pubmed-article:15791505 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15791505 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15791505 | lifeskim:mentions | umls-concept:C0027947 | lld:lifeskim |
| pubmed-article:15791505 | lifeskim:mentions | umls-concept:C0376545 | lld:lifeskim |
| pubmed-article:15791505 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
| pubmed-article:15791505 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:15791505 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:15791505 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:15791505 | pubmed:dateCreated | 2005-3-25 | lld:pubmed |
| pubmed-article:15791505 | pubmed:abstractText | Fluoroquinolone prophylaxis during neutropenia in patients with cancer has been associated with decreased incidence of gram-negative bacteremia. Bacterial antimicrobial resistance is likely to cause a progressive lack of efficacy of fluoroquinolones, but no convincing evidence from clinicoepidemiologic observations has proved this hypothesis. | lld:pubmed |
| pubmed-article:15791505 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15791505 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15791505 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15791505 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15791505 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15791505 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15791505 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15791505 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15791505 | pubmed:issn | 1537-6591 | lld:pubmed |
| pubmed-article:15791505 | pubmed:author | pubmed-author:DöhnerHartmut... | lld:pubmed |
| pubmed-article:15791505 | pubmed:author | pubmed-author:ReuterStefanS | lld:pubmed |
| pubmed-article:15791505 | pubmed:author | pubmed-author:KernPeterP | lld:pubmed |
| pubmed-article:15791505 | pubmed:author | pubmed-author:KernWinfried... | lld:pubmed |
| pubmed-article:15791505 | pubmed:author | pubmed-author:MarreReinhard... | lld:pubmed |
| pubmed-article:15791505 | pubmed:author | pubmed-author:SiggeAnjaA | lld:pubmed |
| pubmed-article:15791505 | pubmed:author | pubmed-author:von... | lld:pubmed |
| pubmed-article:15791505 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15791505 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15791505 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:15791505 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15791505 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15791505 | pubmed:pagination | 1087-93 | lld:pubmed |
| pubmed-article:15791505 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:meshHeading | pubmed-meshheading:15791505... | lld:pubmed |
| pubmed-article:15791505 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15791505 | pubmed:articleTitle | Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. | lld:pubmed |
| pubmed-article:15791505 | pubmed:affiliation | Section of Infectious Diseases and Clinical Immunology, Department of Internal Medicine III, University Hospital of Ulm, Germany. stefan.reuter@medizin.uni-ulm.de | lld:pubmed |
| pubmed-article:15791505 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15791505 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:15791505 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15791505 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15791505 | lld:pubmed |
